Article Details

MaxCyte expects improved full-year revenue on organic growth - Morningstar

Retrieved on: 2022-01-24 15:06:37

Tags for this article:

Click the tags to see associated articles and topics

MaxCyte expects improved full-year revenue on organic growth - Morningstar. View article details on hiswai:

Excerpt

The biotechnology firm ended 2021 with 15 strategic platform license agreements and added four of these during the year. Nonetheless, it only ...

Article found on: www.morningstar.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up